Your browser doesn't support javascript.
loading
Development of novel PP2A activators for use in the treatment of acute myeloid leukaemia.
Toop, Hamish D; Dun, Matthew D; Ross, Bryony K; Flanagan, Hayley M; Verrills, Nicole M; Morris, Jonathan C.
Affiliation
  • Toop HD; School of Chemistry, UNSW Australia, Sydney, NSW 2052, Australia. jonathan.morris@unsw.edu.au.
  • Dun MD; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW 2308, Australia and Hunter Medical Research Institute, Newcastle, NSW 2305, Australia.
  • Ross BK; Calvary Mater Hospital, Newcastle, NSW 2298, Australia.
  • Flanagan HM; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW 2308, Australia and Hunter Medical Research Institute, Newcastle, NSW 2305, Australia.
  • Verrills NM; School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW 2308, Australia and Hunter Medical Research Institute, Newcastle, NSW 2305, Australia.
  • Morris JC; School of Chemistry, UNSW Australia, Sydney, NSW 2052, Australia. jonathan.morris@unsw.edu.au.
Org Biomol Chem ; 14(20): 4605-16, 2016 May 18.
Article in En | MEDLINE | ID: mdl-27102578

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Design / Leukemia, Myeloid, Acute / Protein Phosphatase 2 / Fingolimod Hydrochloride / Antineoplastic Agents Type of study: Prognostic_studies Language: En Journal: Org Biomol Chem Journal subject: BIOQUIMICA / QUIMICA Year: 2016 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Design / Leukemia, Myeloid, Acute / Protein Phosphatase 2 / Fingolimod Hydrochloride / Antineoplastic Agents Type of study: Prognostic_studies Language: En Journal: Org Biomol Chem Journal subject: BIOQUIMICA / QUIMICA Year: 2016 Document type: Article Affiliation country: Australia Country of publication: United kingdom